Progress in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Umbilical Cord Blood Mononuclear Cells

Investigators focus on safety and efficacy, the route of administration, dose, timing and combination treatment of cord blood-derived mononuclear cells in hypoxic-ischemic encephalopathy.